OVARIAN CANCER and US: kidney cancer

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label kidney cancer. Show all posts
Showing posts with label kidney cancer. Show all posts

Monday, March 28, 2011

Expert Review - slides: Renal Cell Carcinoma Biology and the Rationale for VEGF (sorafenib, sunitinib, erlotinib, avastin, interleukins, etc)



Note: if you are unable to access this slide presentation it is because you need to register on the site (free); it may be of interest to those with clear cell ovarian cancer; the largest % of renal cancers are of the clear cell subtype (a known ~75%)

-------------------------------------------------------------------------------------------------------

MODULE 1: Renal Cell Carcinoma Biology and Rationale for VEGF
Expert review with Lee Lokey, MD, and Brian I. Rini, MD, focusing on renal cell carcinoma
Discussant: Brian I. Rini, MD—Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States
Interviewed by: Lee Lokey, MD—prIME Oncology, Atlanta, Georgia, United States

Saturday, July 24, 2010

Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer (see 'Note')



Note: while not ovarian cancer specific (noting the common cell type of clear cell) the conclusion is interesting

CONCLUSION: We identified overweight as an independent prognostic marker of improved cancer specific survival in patients with organ-confined but not advanced RCC. Basic research is required to resolve the dilemma of why, if a higher BMI predisposes to RCC, it concurrently prolongs survival after patients have undergone (partial) nephrectomy.